Zhongnan Medical Journal Press

Home Results

A total of 10 result was found. Results that relate to LIU Min

A case of severe immune liver injury caused by pembrolizumab and rechallenge

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):212-217.
9871 times 2586 times

LIU Min YANG Limei YIN Yue ZHAO Bingqing

Pembrolizumab Immune related liver injury Rechallenge of immunotherapy
Details
Determination of related substances in gluaric anhydride by HPLC

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):382-387.
11571 times 2398 times

LIU Min LIAN Zhenxia LIU Yanxin WANG Fan LI Xia YANG Haixia

Glutaric anhydride Succinic acid Adipic acid Related substances High performance liquid chromatography
Details
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(6):690-701.
22492 times 2892 times

ZHANG Bin LIU Minna LI Xiaolin LI Jinhu LIU Tianlong

National centralized drug procurement Real world study Clinical evaluation Generic drugs Innovator drugs Effectiveness Safety
Details
Prediction of the mechanism of Wuyao decoction lyophilized powder in treating primary dysmenorrhea based on fingerprint and network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2025,29(6):912-923.
12166 times 1627 times

CHENG Hao HAN Danrui CHU Suxia LIU Mingsong MA Donglai DUAN Xuhong

Wuyao decoction Lyophilized powder Primary dysmenorrhea Ultra performance liquid chromatography Fingerprint Network pharmacology Mechanism of action
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (10): an overview and case study of quality assessment tools

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1113-1126.
8885 times 1697 times

ZHENG Qingyong XU Caihua ZHOU Yongjia TANG Xiao ZHANG Mengjun QI Jinzhi LIU Ming GAO Ya SUN Feng TIAN Jinhui

Pharmacoepidemiology Methodology Guildelines Quality assessment tools Risk of bias
Details
An introduction to Risk of Bias in Network Meta-analysis (RoB NMA) tool

Published on New Medicine 2025,35(12):1454-1463.
10387 times 1283 times

ZHAO Wenshuo LIU Ming SHI Jiyuan LI Lun YANG Fengwen XUE Fuzhong GAO Ya

Systematic review Network-Meta-analysis RoB NMA Risk of bias Interpretation
Details
Analysis of adverse events associated with cetuximab based on the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2026,30(1):87-97.
4015 times 911 times

RUI Wenyue LIU Jiahui QIAO Qian CHEN Zhaofeng LIU Min

Cetuximab FAERS Database Adverse events Pharmacovigilance Signal mining Bayesian confidence propagation neural network Proportional report ratio Drug-drug interactions
Details
Meta-integration of qualitative studies on the inner experience and nursing needs of breast cancer patients during radiotherapy and chemotherapy

Published on New Medicine 2026,36(1):88-96.
8810 times 1166 times

ZHANG Xin ZHU Baoling LIU Min HE Jingjing

Breast cancer Radiotherapy and chemotherapy Inner experience Nursing needs Qualitative research Meta-integration
Details
Ultrasound features of 33 cases of histiocytic necrotizing lymphadenitis in children

Published on New Medicine 2026,36(2):231-235.
4860 times 958 times

LI Chao LIU Min

Histiocytic necrotizing lymphadenitis Children Ultrasonographic features Retrospective analysis
Details
Changes in the burden of atopic dermatitis, asthma, and urticaria in China from 1990 to 2023

Published on New Medicine 2026,36(7):782-789.
695 times 172 times

WU Jiarong JIN Qiubai LIU Xinqian LIU Mingyue ZHANG Ningxin SUN Meiqi SONG Ping

Atopic dermatitis asthma urticaria Allergic diseases Disease burden Disability-adjusted life year
Details